Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Choline transporter-like protein 4 (CTL4), encoded by the SLC44A4 gene, is a choline transporter involved in both neuronal and non-neuronal acetylcholine synthesis. In the olivocochlear bundle, it supports hair cell function and protects against acoustic injury. Outside the nervous system, CTL4 mediates acetylcholine synthesis and secretion in tissues like lung and colon cancer cells, offering a potential target for modulating cholinergic signaling without affecting neuronal pathways. Its role in non-neuronal acetylcholine production is particularly relevant for cancer research and potential therapeutic interventions in immune and degenerative diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Choline Transporter-Like Protein 4 (CTL4).